Livzon Pharmaceutical Group Inc. (SHE: 000513)
China
· Delayed Price · Currency is CNY 37.12
-0.20 (-0.54%)
Nov 15, 2024, 3:04 PM CST
Livzon Pharmaceutical Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | Jan '20 Jan 1, 2020 | 2019 - 2015 |
| Market Capitalization | 30,038 | 28,292 | 27,456 | 32,307 | 33,156 | 27,652 | Upgrade
|
| Market Cap Growth | 9.67% | 3.04% | -15.01% | -2.56% | 19.91% | 64.48% | Upgrade
|
| Enterprise Value | 24,107 | 22,700 | 22,297 | 27,114 | 27,086 | 21,498 | Upgrade
|
| Last Close Price | 37.12 | 33.75 | 30.04 | 35.71 | 35.06 | 28.34 | Upgrade
|
| PE Ratio | 16.96 | 16.07 | 14.72 | 18.81 | 19.16 | 20.39 | Upgrade
|
| Forward PE | 15.47 | 17.25 | 16.36 | 18.28 | 21.60 | 17.51 | Upgrade
|
| PS Ratio | 2.89 | 2.28 | 2.17 | 2.68 | 3.15 | 2.95 | Upgrade
|
| PB Ratio | 2.40 | 1.92 | 1.84 | 2.26 | 2.43 | 2.25 | Upgrade
|
| P/TBV Ratio | 2.42 | 2.10 | 2.08 | 2.56 | 2.82 | 2.55 | Upgrade
|
| P/FCF Ratio | 12.71 | 11.65 | 14.98 | 54.46 | 21.90 | 20.20 | Upgrade
|
| P/OCF Ratio | 9.87 | 8.71 | 9.90 | 16.98 | 15.34 | 15.65 | Upgrade
|
| PEG Ratio | 0.80 | 0.80 | 0.80 | 1.08 | 1.44 | 0.29 | Upgrade
|
| EV/Sales Ratio | 2.03 | 1.83 | 1.77 | 2.25 | 2.57 | 2.29 | Upgrade
|
| EV/EBITDA Ratio | 7.26 | 8.31 | 8.70 | 11.58 | 11.19 | 12.23 | Upgrade
|
| EV/EBIT Ratio | 10.25 | 11.81 | 11.54 | 14.14 | 13.35 | 15.65 | Upgrade
|
| EV/FCF Ratio | 9.02 | 9.35 | 12.17 | 45.71 | 17.89 | 15.70 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.28 | 0.24 | 0.19 | 0.14 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 1.23 | 1.50 | 1.40 | 1.14 | 0.80 | 0.77 | Upgrade
|
| Debt / FCF Ratio | 1.53 | 1.71 | 1.97 | 4.54 | 1.27 | 0.99 | Upgrade
|
| Asset Turnover | 0.48 | 0.50 | 0.53 | 0.56 | 0.55 | 0.53 | Upgrade
|
| Inventory Turnover | 2.13 | 2.32 | 2.47 | 2.74 | 2.82 | 3.01 | Upgrade
|
| Quick Ratio | 1.58 | 1.86 | 1.97 | 1.83 | 2.13 | 2.16 | Upgrade
|
| Current Ratio | 1.84 | 2.14 | 2.30 | 2.12 | 2.40 | 2.43 | Upgrade
|
| Return on Equity (ROE) | 15.09% | 12.78% | 13.37% | 13.97% | 16.45% | 12.17% | Upgrade
|
| Return on Assets (ROA) | 5.91% | 4.81% | 5.11% | 5.58% | 6.58% | 4.85% | Upgrade
|
| Return on Capital (ROIC) | 7.84% | 6.41% | 6.79% | 7.36% | 8.69% | 6.39% | Upgrade
|
| Earnings Yield | 5.90% | 6.91% | 6.95% | 5.50% | 5.17% | 4.71% | Upgrade
|
| FCF Yield | 7.87% | 8.58% | 6.67% | 1.84% | 4.57% | 4.95% | Upgrade
|
| Dividend Yield | 3.62% | 4.00% | 5.33% | 3.64% | 3.56% | 4.06% | Upgrade
|
| Payout Ratio | 67.66% | 81.36% | 83.33% | 70.81% | 64.15% | 66.66% | Upgrade
|
| Buyback Yield / Dilution | 0.74% | 0.56% | 0.04% | 0.25% | -0.41% | -0.20% | Upgrade
|
| Total Shareholder Return | 4.36% | 4.56% | 5.36% | 3.89% | 3.16% | 3.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.